Context. High concentrations of inspired oxygen contribute to the pathogenesis of neonatal bronchopulmonary dysplasia and adult acute respiratory distress syndrome. Animal models of hyperoxia-associated lung injury (HALI) are characterised by enhanced generation of reactive oxygen species (ROS) and an adaptive anti-oxidant response. ROS contribute to pathogenesis, partly through enhancing pro-inflammatory activity in macrophages.
Introduction
Hyperoxia-associated lung injury (HALI) is a consequence of sustained exposure to high concentrations of inspired oxygen. It is understood to contribute to the pathogenesis of neonatal bronchopulmonary dysplasia (BPD) (Bourbon et al., 2005) and adult respiratory distress syndrome (ARDS) (Branson and Robinson, 2011, de Graaff et al., 2011) , when sustained high inspired oxygen concentrations are required in treatment. In those clinical conditions, hyperoxia acts on the background of an immature respiratory system in BPD or lungs that already harbour serious pathology in ARDS, making the exact contribution of HALI difficult to measure. HALI has been successfully modelled in many other mammalian species (Fracica et al., 1991 , Frank et al., 1978 , Matute-Bello et al., 2008 . Early pathology includes death of alveolar type I pneumocytes and capillary endothelial cells, accumulation of polymorphonuclear leukocytes, macrophage activation and oedema (Donnelly et al., 1993 , Gore et al., 2010 . Fibroblast proliferation and scarring follow in survivors (Matute-Bello et al., 2008) . In human BPD and ARDS, the pathology reflects the sum effects of the background condition and hyperoxic exposure (Altemeier and Sinclair, 2007, Bourbon et al., 2005 ).
Oxygen toxicity is substantially mediated through reactive oxygen species (ROS) (Freeman and Crapo, 1981 , Fridovich, 1978 , including the generation of superoxide (O 2
•-) in mitochondria (Freeman and Crapo, 1981 , Turrens et al., 1982 , Brueckl et al., 2006 . Further reduction of O 2
•-yields hydrogen peroxide and hydroxyl radical. Known critical targets of ROS attack include lipids, transporters, pro-and anti-apoptotic proteins, transcription factors, kinases and mitochondrial proteins (Gore et al., 2010 , Halliwell, 2007 .
Systems of low molecular weight reductants, sulfhydryl-containing protein reductants, superoxide dismutases and peroxidases act to detoxify ROS generated in mitochondria (Limon-Pacheco and Gonsebatt, 2009 ). These are complemented by cytosolic and 6 extracellular antioxidant systems. Elements of both the mitochondrial and extramitochondrial systems are inducible, providing an adaptive response to increased oxidative stress that can be invoked during the non-physiological stress of hyperoxia (Gore et al., 2010) . Hyperoxia increases signaling through the NF-B pathway and through nuclear factor erythroid derived 2-related transcription factor 2 (Nrf2) (Cho et al., 2002) . This contributes to the induced anti-oxidant response.
Polymorphonuclear leukocytes and macrophages represent the innate immune response in HALI, BPD and ARDS (Cho et al., 2002 , D'Angio et al., 1995 . The canonical NF-B pathway transduces inflammatory and survival signaling in macrophages (Pagliari et al., 2000) . Hyperoxia increases NF-B signaling activity (Pepperl et al., 2001) in macrophages, an effect that is understood to be ROS-mediated (Gore et al., 2010, Morgan and Liu, 2011) .
As a presumed consequence, NF-B signaling is enhanced in models of HALI (Gore et al., 2010) . A similar increase in NF-B activity occurs in alveolar macrophages of ARDS patients (Schwartz et al., 1996) . In experimental HALI (Gore et al., 2010 , D'Angio et al., 2004 , Donnelly et al., 1993 and ARDS (Perl et al., 2011 , Tsushima et al., 2009 this is accompanied by increases in the NF-B-regulated macrophage cytokines, IL-1β, TNFα and IL-8. NF-B-mediated macrophage activation and subsequent lung inflammation appear to play a key role in BPD pathogenesis also (Blackwell et al., 2011) .
In addition to the ROS-inducible NF-B and Nrf2 antioxidant pathways, we have recently observed that macrophages rapidly increase expression of mitochondrial uncoupling protein-2 (UCP2) in circumstances of increased mitochondrial ROS generation (Giardina et al., 2008) . UCP2 belongs to the superfamily of inner mitochondrial membrane anion-carrier proteins that also includes UCP's 1, 3, 4 and 5, the adenine nucleotide translocases and the phosphate, oxoglutarate/malate, carnitine, citrate, ornithine and dicarboxylate carriers 7 (Nicholls and Locke, 1984 , Nedergaard and Cannon, 2003 , Fleury et al., 1997 . It is nuclearencoded. UCP2 expression in the inner mitochondrial membrane lowers mitochondrial O 2
•-production (Negre-Salvayre et al., 1997) . This is consistent with a mild uncoupling function which dissipates the mitochondrial membrane potential (Δψ m ) (Miwa et al., 2003) . The importance of UCP2 regulation is revealed in macrophages of homozygous ucp2 genedeleted mice, where increased ROS generation perturbs innate immune function (Arsenijevic et al., 2000) . Isolated cells of various lineages have shown comparable results (Kizaki et al., 2002 , Teshima et al., 2003 .
Approximately one third of the total organ expression of UCP2 in lung is in pulmonary macrophages (Pecqueur et al., 2001 , Alves-Guerra et al., 2003 . Hyperoxia increases mitochondrial ROS generation (Freeman and Crapo, 1981 , Turrens et al., 1982 , Brueckl et al., 2006 , and UCP2 is rapidly expressed in macrophages under other conditions that increase mitochondrial ROS production (Giardina et al., 2008) . This suggests that hyperoxia will also induce UCP2 in pulmonary macrophages. That, in turn, would invite the hypothesis that UCP2 induction in macrophages will curtail the increase in mitochondrial ROS production that accompanies hyperoxia. The work reported here addresses these postulates and explores the regulatory mechanisms behind hyperoxia-induced UCP2 expression in macrophages. For protein and mRNA analysis of whole lung, groups of 5 animals were sacrificed after periods of hyperoxic exposure (1, 4, 8 and 24 h) or normoxia. Lungs were collected as previously described (Lan et al., 2004) and immediately placed in ice-cold Dulbecco's PBS.
Materials and Methods

Hyperoxic exposure of animals, collection of lung tissue and bronchoalveolar lavage
The upper lobes of the right lungs were snap frozen in liquid nitrogen and used for later mRNA analysis. Bronchoalveolar lavage (BAL) was performed on groups of animals at pre-exposure (n = 10), 1 h (n = 8) and 4 h (n = 8) of O 2 exposure, as previously described (Peters et al., 2010) .
Differential cell counts were performed on Diff-Quick stained and CD68-immunohistochemically labeled BAL cytospin preparations. Macrophages constituted ≥ 95% of cells in the BAL of all animals at each time point.
Immunocytochemistry of BAL cells
BAL cells were dual stained for UCP2 and the macrophage marker, CD68, by the following method. Cytospin preparations were initially fixed for 5 min with 4% paraformaldehyde in PBS, washed with 0.5M NaCl pH 7.4 for 5 min, air dried and frozen at -80C until use. After thawing at room temperature for 10 min, cytospin spots were circled with a PAP pen and given three, 5 min washes in PBS. Cells were then permeabilised for 15 min with PBS containing 0.05% Triton-X-100 and 10% normal donkey serum (NDS: Sigma-Aldrich). After (Giardina et al., 2008) .
Preparations were mounted in ProLong Gold antifade reagent containing DAPI as the nuclear counterstain (AbD SeroTec), sealed and kept in the dark at 4  C until viewed on a Nikon A1 confocal microscope (Shinjuku, Tokyo, Japan) at 60X magnification. Captured image files were converted to TIFF files for analysis using ImageJ software (Abramoff et al., 2004) . The mean UCP2 signal above background per CD68 positive cell was calculated for each slide.
For each condition (normoxia, 1h hyperoxia and 4h hyperoxia), a mean of  45 cells per mouse were individually quantitated.
Cell lines and reagents
The murine macrophage cell line, RAW 264.7 , was obtained from the American Type Culture Collection (ATCC). Cells were maintained in Dulbecco's Modified Eagle Medium (DMEM:
Invitrogen) supplemented with 10% low endotoxin foetal calf serum (FCS) (Bovogen, Australia), penicillin and gentamicin (DMEM/FCS). Cells were incubated in DMEM/FCS in a humidified atmosphere of 5% CO 2 / 95% air at 37C or in hyperoxic conditions as described below. Primary murine bone marrow-derived monocyte/macrophages (BMDM) were isolated from long bones of BALB/c mice, as previously described (Yip et al., 2005) and expanded in 75 cm 2 culture flasks for 7 days in DMEM/FCS supplemented with 40 ng/ml of human macrophage-colony stimulating factor-1 (R&D Systems) (DMEM/FCS/CSF-1).
Other reagents were supplied by Sigma-Aldrich, except where indicated.
Hyperoxic and normoxic cell culture conditions
For studies on UCP2 protein and mRNA levels, RAW 264.7 cells (2.5x10 Control cells were maintained similarly, supplied with 95% air and 5% CO 2 .
UCP2 protein analysis
Following exposure to hyperoxia (0.5, 1, 2 or 4 h) or normoxia, BMDM and RAW 264.7 cells were immediately rinsed twice with 5ml of ice cold DPBS and then lysed in NP40 lysis buffer (10mM Tris, 50mM NaCl, 30mM Na 4 P 2 O 7 .10 H 2 O, 100mM NaF, 5M ZnCl 2 , 1mM antibodies. After three 10 min washes in TTBS, the resolved bands were visualized by enhanced chemiluminescence (ECL) detection reagents (GE Healthcare) using a biomolecular imager (LAS 4000, GE Healthcare). Densitometric quantitation of images was performed using ImageQuant TL Imaging Software, Version 7.0 (GE Healthcare). Statistical analysis of treatment effects on UCP2 expression employed data that was normalised for -actin or VDAC1 (voltage-dependent anion channel-1) expression.
Antibodies
Primary antibodies were goat anti-UCP2 (SC-6525, 1:1000, Santa Cruz), monoclonal mouse anti-β-actin (A-5441, 1: 5000, Sigma-Aldrich), goat anti-VDAC1 (SC-8828, 1:1,000, Santa Cruz) and mouse IgG1 anti MnSOD (M99920/611580, 1:2500, BD Transduction Laboratories). Secondary antibodies used were donkey anti-goat HRP (SC-2020, 1:10 000, Santa Cruz) and sheep anti-mouse HRP (NXA931, 1:10 000, GE Healthcare). Prior to re-probing, membranes were stripped according to published methods (Yeung and Stanley, 2009 ).
mRNA analysis
Frozen lung samples from animals exposed to hyperoxia were transferred to a liquid nitrogen-chilled Biopulverizer (Biospec Products, OK, USA) and processed according to the manufacturer's instructions. Total mRNA was prepared from the resulting powdered lung by 13 following the manufacturer's protocol for animal tissues using the RNeasy® Protect Mini Kit (Qiagen).
Cells that had been exposed to hyperoxia (0.25, 0.5, 1, 2 and 4 h) or cultured in normoxic conditions were rinsed twice with 5ml of ice cold DPBS before lysis in 350l of RNAeasy® lysis buffer. Total mRNA was then isolated.
The Omniscript Reverse Transcriptase Kit (Qiagen) was used for first-strand cDNA synthesis. PCR reactions were completed using an IQ5 Multicolor Real-Time PCR Detection System (Bio-Rad) and SYBR Green PCR MasterMix (Bio-Rad). Samples of cDNAs (equivalent to 20 ng of total mRNA) were amplified by target specific primers for UCP2; melt temperature gradient curve carried out on final reaction products confirmed that a single product had formed. Each sample was normalised using its RPLP0 content as internal reference, and data are expressed as relative abundance of UCP2 mRNA over RPLP0 mRNA.
Mitochondrial membrane potential and superoxide production RAW 264.7 cells and BMDM cultures, prepared as described above, were exposed to hyperoxia for 0.5, 1 or 2 h or to normoxia. Mitochondrial O 2
•-production was measured by the dihydroethidium (DHE; Invitrogen) reduction method and Δψ m was measured using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazol carbocyanine iodide (JC-1; Invitrogen), as 14 previously described (Giardina et al., 2008) . 
Intracellular ATP levels
The ATP content of RAW 264.7 cells and BMDM cultures that had been exposed to hyperoxia for 0.5, 1 or 2 h, or to normoxia, were analyzed using the CellTiter-Glo cell viability assay (Promega Corporation), as per manufacturer's instructions. Luminescent intensities (in relative light units; RLU) are directly proportional to ATP concentrations and were detected using a microplate reader (POLARstar OPTIMA, BMG, Germany). Results are normalised to ATP levels (RLU) of normoxic controls.
Statistical analysis
Statistical differences between control and test groups were analysed by t-test after data normalisation where appropriate. Results are presented as means ± S.E.M.
Results
UCP2 protein levels increase in lungs of mice exposed to hyperoxia
Mice complete up to 48 h of exposure to ≥95% O 2 without manifesting clinical evidence of illness. All experiments were concluded by 24 h. Starting from 1 h of ≥95% O 2 exposure, mitochondria-enriched fractions from whole lung extracts exhibited increased levels of UCP2 protein (Figure 1 ; P < 0.05). Levels were maximal at 4 h exposure (P < 0.001). Elevated levels persisted to at least 8 h (Figure 1 ; P < 0.001), followed by a fall to slightly below preexposure levels at 24 h.
Hyperoxia increases UCP2 levels in bronchoalveolar macrophages
Alveolar macrophages are the principal cell type found in BAL fluid in healthy mice. BAL was therefore performed on groups of mice before O 2 exposure and up until 4 h of exposure to ≥95% O 2 , corresponding to the time of maximal levels of UCP2 in lung. Macrophages represented ≥95% of cells in BAL in all mice at all time points, as identified by stained morphology and CD68 positivity (Figure 2A ). UCP2 levels were measured by quantitative immunohistochemistry on cytocentrifuge preparations. UCP2 abundance increased from 1 h and was significantly greater than normoxic controls at 4 h ( Figure 2B : P < 0.005). These experiments identified macrophages as targets for hyperoxic induction of mitochondrial UCP2 in the lung.
Non-macrophage cells were present in only low numbers in BAL and did not show a noticeable enhancement of UCP2 signal with hyperoxia.
Hyperoxia increases UCP2 levels in bone marrow-derived macrophages and murine RAW 264.7 macrophages.
Alveolar macrophages are terminally-differentiated cells of the bone marrow-derived monocyte/macrophage lineage. We therefore sought to determine whether hyperoxic induction of UCP2 was a general attribute of the lineage, by studying precursor BMDM.
BMDM were isolated as described in methods and cultured for up to 4 h under hyperoxic conditions. UCP2 in BMDM was sufficiently abundant to be measurable on whole cell extracts, without the need for mitochondrial enrichment ( Figure 3A and C). There was a rapid induction of UCP2 protein, apparent at 30 min and significant by 1 h (P < 0.05), before declining to pre-exposure levels from 2 h. Hyperoxic induction was not unique to primary macrophages, but was also apparent in the RAW 264.7 macrophage cell line, with a comparable time course (Figure 3B and D) . The RAW 264.7 cell line is a relatively well differentiated, Abelson murine leukaemia virus-transformed, murine macrophage line. These experiments showed that the hyperoxic induction of UCP2 in pulmonary alveolar macrophages generalises to other macrophages, both primary and transformed. UCP2 induction precedes adaptive anti-oxidant responses that have been reported in pulmonary tissue or macrophages, including the induction of MnSOD (Cho et al., 2002 , Ishii et al., 2000 , Schwartz et al., 1996 , Warner et al., 1996 . Consistent with these previous reports, we found that protein levels for mitochondrial manganese superoxide dismutase (MnSOD) varied by less than 5% over the 4 h of hyperoxia in the same BMDM and RAW 264.7 cell cultures ( Figure 6 ). BMDM and RAW 264.7 cultures remained fully viable for at least 24 h in hyperoxia, as assessed by trypan blue exclusion (results not shown).
The response to hyperoxia is reminiscent of our earlier observation of increased UCP2 in macrophages after exposure to toxins that increase mitochondrial ROS production (Giardina et al., 2008) . This suggested that increased UCP2 in hyperoxia may also be related to enhanced mitochondrial ROS production.
Hyperoxia increases UCP2 levels by a post-transcriptional mechanism
To gain insight into the mechanism of UCP2 regulation by O 2 concentration, UCP2 mRNA was measured in whole lung preparations from hyperoxia-exposed mice, in BMDM and in RAW 264.7 cells. There was a small (32%) increase in UCP2 mRNA at 1 h in whole lung extracts. This was not reproduced at other time points ( Figure 4A ). UCP2 mRNA is expressed in a broader range of cells and tissue than the protein (Mattiasson and Sullivan, 2006, Nedergaard and Cannon, 2003) , allowing the possibility that the small increment at 1 h reflected expression in other pulmonary cell types, or that a real increase in macrophage UCP2 mRNA at other times had been overshadowed by stable expression in other pulmonary cell types. We therefore also examined UCP2 mRNA expression in-vitro, in cultures of BMDM and RAW 264.7 macrophages. There was no increase in UCP2 mRNA in BMDM or RAW 264.7 cells over a time course that spanned the hyperoxia-induced increases in UCP2 protein in these cells ( Figure 4B and 4C). These findings indicated that transcription was, at most, a minor contributor to hyperoxic regulation of UCP2 in pulmonary alveolar macrophages.
UCP2 mRNA levels in whole lung declined significantly at 24 h, similar to changes in mitochondrial UCP2 protein at this time point (Figure 1, Figure 4 ).
Functional associations of enhanced UCP2 levels
To better define the functional significance of UCP2 induction in hyperoxia-exposed macrophages, we measured two mitochondrial functions that are closely linked to UCP2 levels, Δψ m and mitochondrial O 2
•-generation.
Mitochondrial O 2
•-generation was estimated from oxidation of dihydroethidium (DHE) to its DNA-conjugated fluorogenic product, ethidium in BMDM and in RAW 264.7 cell cultures.
Fifteen minutes of exposure to 95% O 2 increased ethidium fluorescence significantly in both BMDM and RAW 264.7 macrophages, compared with normoxia ( Figure 5A and 5B). Neither hyperoxia nor the induction of UCP2 compromised ATP production during the 2 h duration of these experiments ( Figure 5E and 5F). There were, in fact, small increases in ATP in both BMDM and RAW 264.7 cells at 30 min (P < 0.05 in each case). The maintenance of 19 ATP levels argues against the possibility that falling Δψ m reflected a ROS-induced loss of mitochondrial integrity.
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Discussion
We found that hyperoxia rapidly and transiently increased UCP2 protein levels in macrophages without increasing mRNA. Δψ m and mitochondrial O 2
•-generation declined after UCP2 induction. Induction was broadly observed in primary and transformed macrophages in-vitro and in lung macrophages. The mouse model used in these studies replicates early events in HALI, before inflammatory and exudative changes impair gas transfer and pulmonary circulatory function (Matute-Bello et al., 2008) . During this phase, there is increased mitochondrial ROS production and the opportunity for an anti-oxidant response to control it. The anti-oxidant response has been partly characterised through studies on the Nrf2 and NF-B signalling systems in lung and through studies of the regulation of ROS in other cells and tissues, including isolated macrophages (Gore et al., 2010 , Cho et al., 2002 , Franek et al., 2004 . Macrophages are represented in the lung by alveolar macrophages, resident interstitial macrophages and, in pathology, by recruited circulating monocyte/macrophages. Macrophages are notable because of their relatively abundant expression of UCP2 and because UCP2 is induced under circumstances where mitochondrial ROS production increases (Fleury et al., 1997 , Giardina et al., 2008 . A transient increase in mitochondrial O 2
•-generation preceded in-vitro UCP2 induction in these experiments also.
Increased mitochondrial ROS production has been well demonstrated in response to hyperoxia in other systems, but not generally as early as observed here (Brueckl et al., 2006 , Freeman and Crapo, 1981 , Turrens et al., 1982 . A similarly rapid UCP2 accumulation accompanies pharmacological stimulation of mitochondrial ROS generation in macrophages (Giardina et al., 2008) . The observation that UCP2 upregulation followed an initial, hyperoxia-induced burst of mitochondrial O 2
•-generation therefore suggests that mitochondrial O 2
•-itself may be the stimulus for UCP2 induction.
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UCP2 regulates Δψ m and mitochondrial O 2
•-production (Arsenijevic et al., 2000 , Azzu et al., 2010 , Negre-Salvayre et al., 1997 . The hyperoxic induction of UCP2 in macrophages in our studies was linked chronologically to suppression of Δψ m and mitochondrial O 2
These are expected consequences of increased functional UCP2 levels. Despite the suppression of Δψ m , there was no fall in ATP levels during hyperoxia, rather there was a small early increase in levels in both BMDM and RAW 264.7 macrophages. A similar increase has been seen in lung epithelial cells exposed to hyperoxia (Chambellan et al., 2006 ).
Macrophage energy requirements vary according to their state of differentiation, but are primarily supplied from non-mitochondrial sources during inflammatory activation (Vats et al., 2006) , perhaps insulating the energy supply from changes in mitochondrial function.
Although there was a small, very transient induction of UCP2 mRNA in the lungs of hyperoxia-exposed mice, UCP2 mRNA was not induced in isolated primary or transformed macrophages. This is interpreted to mean that hyperoxic induction is through a posttranscriptional mechanism. Post-transcriptional regulation of UCP2 has been previously shown in macrophages exposed to pharmacological inducers of mitochondrial ROS production (Giardina et al., 2008) and in other circumstances (Azzu et al., 2010 , Chen et al., 2009 ). In the INS-1E pancreatic -cell line (Azzu et al., 2010) , Δψ m -and ATP-dependent transfer of UCP2 to cytosolic proteasomes for degradation has been demonstrated, allowing UCP2 to accumulate under conditions of low Δψ m or ATP depletion. The microRNA miR133a has also been shown to directly suppression translation of UCP2 mRNA (Chen et al., 2009) , but this microRNA is not known to be expressed in macrophages.
Induction of UCP2 is early and transient. UCP2 induction precedes other adaptive antioxidant responses mediated through NF-B or Nrf2 pathways in macrophages (Cho et al., 2002 , Ishii et al., 2000 , Schwartz et al., 1996 . In whole lung, UCP2 induction gives way to an overall loss of UCP2 protein and UCP2 mRNA from 24 h. This may correspond with the appearance of other, less immediate, anti-oxidant defences including mitochondrial MnSOD (White and Tsan, 2001, Warner et al., 1996) . In macrophage culture MnSOD responses emerge at 12 to 24 h of oxidant exposure (White and Tsan, 2001, Warner et al., 1996) . Invivo, induced antioxidant responses to hyperoxia are typically apparent at 48 to 72 h (Cho et al., 2002 , Nagata et al., 2007 . Alternatively, the late decline in UCP2 level may be pathological, reflecting mitochondrial damage through ROS exposure (Scatena et al., 2004) , or loss of mitochondrial content during mitochondrial steps of apoptosis. Apoptosis is well described in later stages of HALI (Mantell et al., 1997) . The experiments reported here focussed on the phase of HALI that precedes clinical illness, so were not designed to test whether UCP2 induction in macrophages influences clinical severity or mortality in HALI, or the human illnesses to which HALI contributes, BPD and ARDS. 
Conclusions
